ENTRY       D11777                      Drug
NAME        Seribantumab (USAN/INN)
FORMULA     C6340H9810N1690O1986S52
EXACT_MASS  143060.4067
MOL_WEIGHT  143149.2408
SEQUENCE    (Heavy chain)
            EVQLLESGGG LVQPGGSLRL SCAASGFTFS HYVMAWVRQA PGKGLEWVSS ISSSGGWTLY
            ADSVKGRFTI SRDNSKNTLY LQMNSLRAED TAVYYCTRGL KMATIFDYWG QGTLVTVSSA
            STKGPSVFPL APCSRSTSES TAALGCLVKD YFPEPVTVSW NSGALTSGVH TFPAVLQSSG
            LYSLSSVVTV PSSNFGTQTY TCNVDHKPSN TKVDKTVERK CCVECPPCPA PPVAGPSVFL
            FPPKPKDTLM ISRTPEVTCV VVDVSHEDPE VQFNWYVDGV EVHNAKTKPR EEQFNSTFRV
            VSVLTVVHQD WLNGKEYKCK VSNKGLPAPI EKTISKTKGQ PREPQVYTLP PSREEMTKNQ
            VSLTCLVKGF YPSDIAVEWE SNGQPENNYK TTPPMLDSDG SFFLYSKLTV DKSRWQQGNV
            FSCSVMHEAL HNHYTQKSLS LSPGK
            (Light chain)
            QSALTQPASV SGSPGQSITI SCTGTSSDVG SYNVVSWYQQ HPGKAPKLII YEVSQRPSGV
            SNRFSGSKSG NTASLTISGL QTEDEADYYC CSYAGSSIFV IFGGGTKVTV LGQPKAAPSV
            TLFPPSSEEL QANKATLVCL VSDFYPGAVT VAWKADGSPV KVGVETTKPS KQSNNKYAAS
            SYLSLTPEQW KSHRSYSCRV THEGSTVEKT VAPAECS
            (Disulfide bridge: H22-H96, H133-L216, H146-H202, H221-H'221, H222-H'222, H225-H'225, H228-H'228, H259-H319, H365-H423, H'22-H'96, H'133-L'216, H'146-H'202, H'259-H'319, H'365-H'423, L22-L90, L139-L198, L'22-L'90, L'139-L'198)
  TYPE      Peptide
EFFICACY    Antineoplastic, Anti-HER3 antibody
  TYPE      Monoclonal antibody
TARGET      ERBB3 (HER3) [HSA:2065] [KO:K05084]
  PATHWAY   hsa04012(2065)  ErbB signaling pathway
BRITE       Target-based classification of drugs [BR:br08310]
             Protein kinases
              Receptor tyrosine kinases (RTK)
               EGFR family
                ERBB3 (HER3)
                 D11777  Seribantumab (USAN/INN)
DBLINKS     CAS: 1334296-12-6
            PubChem: 405226643
///
